HGF-Induced PD-L1 Expression in Head and Neck Cancer: Preclinical and Clinical Findings

Head and neck squamous cell carcinoma (HNSCC) is a widespread disease with a low survival rate and a high risk of recurrence. Nowadays, immune checkpoint inhibitor (ICI) treatment is approved for HNSCC as a first-line treatment in recurrent and metastatic disease. ICI treatment yields a clear surviv...

Descripción completa

Detalles Bibliográficos
Autores principales: Boschert, Verena, Teusch, Jonas, Aljasem, Anwar, Schmucker, Philipp, Klenk, Nicola, Straub, Anton, Bittrich, Max, Seher, Axel, Linz, Christian, Müller-Richter, Urs D. A., Hartmann, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699574/
https://www.ncbi.nlm.nih.gov/pubmed/33233528
http://dx.doi.org/10.3390/ijms21228770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699574/
https://www.ncbi.nlm.nih.gov/pubmed/33233528
http://dx.doi.org/10.3390/ijms21228770

Ejemplares similares